Company Filing History:
Years Active: 2018
Title: Annette Christoph: Innovator in Pain Management
Introduction
Annette Christoph is a notable inventor based in Aachen, Germany. She has made significant contributions to the field of pain management, particularly in the context of patients with impaired hepatic and renal function. Her innovative work has led to the development of a unique treatment option that addresses a critical need in healthcare.
Latest Patents
Annette Christoph holds a patent for Cebranopadol, which is designed for treating pain in subjects with impaired hepatic and/or renal function. The invention relates to Cebranopadol or a physiologically acceptable salt thereof for use in the treatment or prevention of pain and/or opioid drug dependence in such patients. This patent highlights her commitment to improving patient outcomes in challenging medical scenarios. She has 1 patent to her name.
Career Highlights
Throughout her career, Annette has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with Grünenthal GmbH and Park Therapeutics, Inc. Her experience in these organizations has allowed her to collaborate with leading experts and contribute to groundbreaking research in pain management.
Collaborations
Annette Christoph has collaborated with esteemed colleagues, including Elke Kleideiter and Rene Fussen. These partnerships have enriched her research and development efforts, fostering an environment of innovation and shared knowledge.
Conclusion
Annette Christoph's work in the field of pain management exemplifies her dedication to advancing medical treatments for vulnerable patient populations. Her innovative patent for Cebranopadol represents a significant step forward in addressing the complexities of pain management in individuals with impaired organ function.